Key Metrics
MARKET CAP
$23.48B
P/E RATIO
24.2
BETA
0.68
Less volatile
DIV YIELD
1.63%
52W HIGH
$213.20
52W LOW
$157.20
VOLATILITY
30.8%
30d annualized
Price Performance
30-DAY PRICE CHART
$184.24 → $211.10+14.58%
30 days agoToday
1-YEAR PERFORMANCE
$172.90 → $211.10+22.1%
DGX | 52-week chartLast updated: 2/27/2026
Healthcare Sector Context
Competitors Analysis
Technical Analysis
Quest Diagnostics is currently trading at $211.10, which is 1.0% below its 52-week high. With a beta of 0.68, the stock shows lower sensitivity to market movements.
RSI (14)OVERBOUGHT
30-DAY TRENDBULLISH
VOLUME0.6M(Below avg)
Frequently Asked Questions
Is DGX a good buy right now?
Quest Diagnostics trades at 24.2x earnings. This is near market average. Current risk level is High based on 30.8% volatility.
Does DGX pay dividends?
Yes, Quest Diagnostics offers a dividend yield of 1.63%. This translates to approximately $3.44 per share annually.
How volatile is DGX?
With 30-day annualized volatility of 30.8% and beta of 0.68,DGX is classified as High risk. The stock tends to be more stable than the market average.
Related Assets
LLYANALYZE →
Eli Lilly and Company
NVOANALYZE →
Novo Nordisk A/S
UNHANALYZE →
UnitedHealth Group
JNJANALYZE →
Johnson & Johnson
ABBVANALYZE →
AbbVie Inc.
Track DGX Live
Add Quest Diagnostics to your Portfolio Terminal for real-time alerts and risk updates.
OPEN TERMINALLast updated: 2/27/2026, 2:03:54 PM